Advice
About this briefing
Medtech innovation briefings summarise the published evidence and information available for individual medical technologies. The briefings provide information to aid local decision‑making by clinicians, managers and procurement professionals.
Medtech innovation briefings aim to present information and critically review the strengths and weaknesses of the relevant evidence, but contain no recommendations and are not formal NICE guidance.
Development of this briefing
This briefing was developed for NICE by Newcastle and York External Assessment Centre. The Interim process & methods statement sets out the process NICE uses to select topics, and how the briefings are developed, quality‑assured and approved for publication.
Project team
Newcastle and York External Assessment Centre
Medical Technologies Evaluation Programme, NICE
Peer reviewers and contributors
-
Helen Cole, Head of Service – Clinical Scientist, Newcastle upon Tyne Hospitals NHS Foundation Trust
-
Mick Arber, Information Specialist, York Health Economics Consortium
-
Derek Bousfield, Senior Clinical Technologist, Newcastle upon Tyne Hospitals NHS Foundation Trust
-
Christine Kimpton, Clinical Scientist, Newcastle upon Tyne Hospitals NHS Foundation Trust
-
Roseanne Jones, Research Scientist, Newcastle upon Tyne Hospitals NHS Foundation Trust
Specialist commentators
The following specialist commentators provided comments on a draft of this briefing:
-
Dr John Andrzejowski, Consultant in Anaesthesia and Neurointensive care, Royal Hallamshire Hospital, Sheffield
-
Dr Nick Fletcher, Consultant Anaesthetist for Cardiothoracic Surgery, St George's University Hospitals NHS Foundation Trust
-
Dr Peter Isherwood, Consultant in Critical Care & Anaesthesia, University Hospitals Birmingham NHS Foundation Trust
Declarations of interest
-
Nick Fletcher has been director of a course on the management of out‑of‑hospital cardiac arrest patients and the Thermogard technology is used in his trust.
-
Peter Isherwood is the clinical lead for targeted temperature management in his trust which routinely uses the Thermogard technology as part of its pathway for comatose survivors of non‑traumatic cardiac arrest.
Copyright
© National Institute for Health and Care Excellence, 2015. All rights reserved. NICE copyright material can be downloaded for private research and study, and may be reproduced for educational and not‑for‑profit purposes. No reproduction by or for commercial organisations, or for commercial purposes, is allowed without the written permission of NICE.
ISBN: 98-1-4731-1431-9